USTCi001-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg Name	USTCi001-A
Cell line type	Human induced pluripotent stem cell (hiPSC)
Last update	27th April 2020
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	School of Life Sciences, University of Science and Technology of China (USTC)
External Databases
Cellosaurus	CVCL_ZE23
Wikidata	Q98134372
General Information
Publications	Zhao H et al. Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy. Stem cell research. 2020 May;45:101785. Zhao H et al. Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem cell research. 2020 Jul;46:101864. Zhao H et al. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing. Stem cell research. 2020 Oct;48:102003. Zhao H et al. A heterozygous SCN1A (c.A5768G/+) mutant human induced pluripotent stem cell line (USTCi002-A) generated using TALEN-mediated precise gene editing. Stem cell research. 2020 Dec;49:102058. Khorkova O et al. Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent Developments. Frontiers in molecular biosciences. 2021;8:643681. Tahbaz M et al. Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes. Frontiers in endocrinology. 2021;12:716625. Zhao H et al. Ameliorating Effect of Umbilical Cord Mesenchymal Stem Cells in a Human Induced Pluripotent Stem Cell Model of Dravet Syndrome. Molecular neurobiology. 2022 Feb;59(2):748-761.
Subclones	USTCi001-A-1 USTCi001-A-2

hIPSC Derivation

General